Home › Funds › Nuveen, LLC › ABBV

Nuveen, LLC position in ABBV

ABBVIE INCORPORATED · Health Care

Nuveen, LLC reported holding 9,735,091 shares of ABBV (ABBVIE INCORPORATED) in its Q3 2026 13F filing — a position valued at US$2.55B, representing 0.61% of its reported portfolio and ranking #25 among its reported holdings. Nuveen, LLC has disclosed ABBV holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)9.74M sh
Reported value held$2.55B
Portfolio Weight0.61%
First reportedQ1 2025
Last changeAdd
Updated2026-11-10

Last updated: 2026-11-10 · Source: SEC EDGAR Form 13F-HR

How Nuveen, LLC's ABBV position evolved

Nuveen, LLC first disclosed a stake in ABBV in Q1 2025 at 8,682,482 shares (US$1.82B). The position peaked in Q3 2026 at 9,735,091 shares, worth US$2.55B. Across 7 filings, Nuveen, LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 9,735,091 shares valued at US$2.55B — an increase of 225,100 shares quarter over quarter.. Notable position changes include a 29% increase in Q1 2026 (shares rose 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 8.68M $1.82B New
Q2 2025 8.36M $1.55B Reduce
Q3 2025 8.08M $1.87B Reduce
Q4 2025 8.61M $1.97B Add
Q1 2026 11.12M $2.42B Add
Q2 2026 9.51M $2.39B Reduce
Q3 2026 9.74M $2.55B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INCORPORATED) is a Health Care company. 34 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Nuveen, LLC held ABBV?

Nuveen, LLC has disclosed ABBV holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Nuveen, LLC's current position in ABBV?

As of Q3 2026, Nuveen, LLC holds 9.74M shares of ABBV (ABBVIE INCORPORATED), valued at $2.55B, representing 0.61% of its reported portfolio and ranking #25.

Has Nuveen, LLC been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Nuveen, LLC increased its position in ABBV. The position peaked in Q3 2026 at 9.74M shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.